EUVIMEDEUVIMED entdecken
Crossref

Cystinuria in clinical practice: challenges in genetic verification and laboratory diagnosis

Polina S. Luganskaya, Daria A. Kandina, Ilyas I. Akhmarov, Oleg A. Kirillov, Julia V. Sopova, Elena I. Leonova

Ecological genetics · 30.06.2026 · 24 (2) · 159-165

DOI: 10.17816/ecogen695654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ecological genetics, online erschienen am 30.06.2026. Verfasst von Polina S. Luganskaya und 5 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystinuria is an inherited disorder caused by impaired reabsorption of cystine and dibasic amino acids—ornithine, lysine, and arginine—in the proximal renal tubules. Ornithine, arginine, and lysine are highly soluble in urine, but the solubility of cystine depends on pH and is low under physiological conditions. The genetic basis of cystinuria involves mutations in the SLC3A1 gene (encoding the heavy subunit rBAT of the Na+-independent amino acid transporter (rBAT-b0,+AT) and the SLC7A9 gene (encoding the light subunit b0,+AT). Dysfunction of the rBAT-b0,+AT transporter leads to excessive cystine excretion, promoting urine supersaturation, crystallization, and the formation of cystine stones. Mutations in SLC7A9 exhibit a broad inheritance spectrum, ranging from recessive to dominant. Mutations in SLC3A1 are usually considered autosomal recessive; heterozygous carriers of these mutations mostly have a normal urinary amino acid profile, whereas homozygotes exhibit various symptoms of cystinuria. Accumulating clinical evidence reveals genotypic–phenotypic discordance that challenges this classical model. This review systematizes atypical cases where heterozygous carriers of pathogenic SLC3A1 mutations manifest recurrent cystine stones and hypercystinuria, whereas family members with identical mutations remain asymptomatic. Notably, approximately 10% of patients lack detectable mutations in the coding regions of these genes, suggesting the potential involvement of non-coding regulatory regions or modifier genes, including but not limited to SLC7A10 (ASC1), SLC1A5 (ASCT2), and SLC7A13 (AGT1). The review concludes that additional methods, such as whole-genome sequencing of well-characterized families, are necessary to identify these hidden genetic factors, improve diagnostic accuracy, and better understand the molecular mechanisms underlying cystinuria.

Zitieren

APA

Luganskaya, P. S., Kandina, D. A., Akhmarov, I. I., Kirillov, O. A., Sopova, J. V., & Leonova, E. I. (2026). Cystinuria in clinical practice: challenges in genetic verification and laboratory diagnosis. Ecological genetics, 24(2), 159-165. https://doi.org/10.17816/ecogen695654

Vancouver

Luganskaya PS, Kandina DA, Akhmarov II, Kirillov OA, Sopova JV, Leonova EI. Cystinuria in clinical practice: challenges in genetic verification and laboratory diagnosis. Ecological genetics. 2026;24(2):159-165. doi:10.17816/ecogen695654

BibTeX
@article{Luganskaya2026,
  author = {Luganskaya, Polina S. and Kandina, Daria A. and Akhmarov, Ilyas I. and Kirillov, Oleg A. and Sopova, Julia V. and Leonova, Elena I.},
  title = {Cystinuria in clinical practice: challenges in genetic verification and laboratory diagnosis},
  journal = {Ecological genetics},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {159--165},
  doi = {10.17816/ecogen695654}
}
Kostenlos starten →